JAMA ophthalmology۲۰۲۴کارآزمایی بالینی تصادفی۱۸ استنادنمایه شده در PubMed
Susan B Bressler, Abhijit Barve, Prasanna C Ganapathi, Katrin Beckmann, Rajendra S Apte, Dennis M Marcus, Kristine Baumane, Somesh Agarwal, Piotr Oleksy, David A Reichstein, Sunil S Patel, Jan Ernest, Rozsa Dégi, Vishali Gupta, Genichiro Kishino, Motohiro Kamei, Subramanian Loganathan, INSIGHT Study Group
چکیده
Biosimilars may be lower-cost alternatives to originator biologic products, potentially offering expanded access or reduced economic burden, but have not been evaluated with aflibercept in diabetic macular edema (DME). To compare efficacy and safety of MYL-1701P, an aflibercept biosimilar, with…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1001/jamaophthalmol.2024.3458